Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 1
2002 1
2003 1
2004 5
2005 4
2006 4
2010 3
2011 3
2013 3
2014 1
2015 1
2016 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
The resurgence of covalent drugs.
Singh J, Petter RC, Baillie TA, Whitty A. Singh J, et al. Among authors: petter rc. Nat Rev Drug Discov. 2011 Apr;10(4):307-17. doi: 10.1038/nrd3410. Nat Rev Drug Discov. 2011. PMID: 21455239 Review.
Acylating drugs: redesigning natural covalent inhibitors.
Kluge AF, Petter RC. Kluge AF, et al. Among authors: petter rc. Curr Opin Chem Biol. 2010 Jun;14(3):421-7. doi: 10.1016/j.cbpa.2010.03.035. Epub 2010 Apr 24. Curr Opin Chem Biol. 2010. PMID: 20457000 Review.
CNS Anticancer Drug Discovery and Development Conference White Paper.
Levin VA, Tonge PJ, Gallo JM, Birtwistle MR, Dar AC, Iavarone A, Paddison PJ, Heffron TP, Elmquist WF, Lachowicz JE, Johnson TW, White FM, Sul J, Smith QR, Shen W, Sarkaria JN, Samala R, Wen PY, Berry DA, Petter RC. Levin VA, et al. Among authors: petter rc. Neuro Oncol. 2015 Nov;17 Suppl 6(Suppl 6):vi1-26. doi: 10.1093/neuonc/nov169. Neuro Oncol. 2015. PMID: 26403167 Free PMC article.
Targeted covalent drugs of the kinase family.
Singh J, Petter RC, Kluge AF. Singh J, et al. Among authors: petter rc. Curr Opin Chem Biol. 2010 Aug;14(4):475-80. doi: 10.1016/j.cbpa.2010.06.168. Epub 2010 Jul 6. Curr Opin Chem Biol. 2010. PMID: 20609616
Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC.
Walter AO, Sjin RT, Haringsma HJ, Ohashi K, Sun J, Lee K, Dubrovskiy A, Labenski M, Zhu Z, Wang Z, Sheets M, St Martin T, Karp R, van Kalken D, Chaturvedi P, Niu D, Nacht M, Petter RC, Westlin W, Lin K, Jaw-Tsai S, Raponi M, Van Dyke T, Etter J, Weaver Z, Pao W, Singh J, Simmons AD, Harding TC, Allen A. Walter AO, et al. Among authors: petter rc. Cancer Discov. 2013 Dec;3(12):1404-15. doi: 10.1158/2159-8290.CD-13-0314. Epub 2013 Sep 24. Cancer Discov. 2013. PMID: 24065731 Free PMC article.
In vitro and in vivo characterization of irreversible mutant-selective EGFR inhibitors that are wild-type sparing.
Tjin Tham Sjin R, Lee K, Walter AO, Dubrovskiy A, Sheets M, Martin TS, Labenski MT, Zhu Z, Tester R, Karp R, Medikonda A, Chaturvedi P, Ren Y, Haringsma H, Etter J, Raponi M, Simmons AD, Harding TC, Niu D, Nacht M, Westlin WF, Petter RC, Allen A, Singh J. Tjin Tham Sjin R, et al. Among authors: petter rc. Mol Cancer Ther. 2014 Jun;13(6):1468-79. doi: 10.1158/1535-7163.MCT-13-0966. Epub 2014 Apr 10. Mol Cancer Ther. 2014. PMID: 24723450 Free article.
28 results